Eli Lilly & Co. said Wednesday that is capping out-of-pocket insulin costs to $35 for people with commercial health insurance at certain retail pharmacies...
Eli Lilly & Co. LLY said Wednesday that is capping out-of-pocket insulin costs to $35 for people with commercial health insurance at certain retail pharmacies and it is also lowering the prices of most its insulins, such as pricing non-branded Insulin Lispro at $25 a vial. The company also plans to cut the list price of Humalog and Humulin in the fourth quarter, though it did not say by how much.
LLY said Wednesday that is capping out-of-pocket insulin costs to $35 for people with commercial health insurance at certain retail pharmacies and it is also lowering the prices of most its insulins, such as pricing non-branded Insulin Lispro at $25 a vial. The company also plans to cut the list price of Humalog and Humulin in the fourth quarter, though it did not say by how much. Further, Lilly said in April it plans to launch a biosimilar to Lantus, which will cost $92 for a five pack of pens.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Eli Lilly caps the cost of insulin at $35 a monthThe move puts the drugmaker in line with a popular provision in the Inflation Reduction Act that capped the medication’s cost for seniors on Medicare.
続きを読む »
Eli Lilly to slash insulin prices, expand cost capEli Lilly has announced plans to cut the price for insulin products later this year and immediately expand a spending cap for insured patients.
続きを読む »
Lilly to cut insulin prices by 70%, cap prices at $35 per month for people with private insurance
続きを読む »
Lilly to cut insulin prices by 70% from fourth quarterBREAKING: U.S. drugmaker Eli Lilly said it would reduce prices by 70% for its most commonly prescribed forms of insulin
続きを読む »
Davis Webb made quick jump to coaching with Eli Manning’s helpEli Manning paid off any debts to Davis Webb for all the hours of extra film study that the rookie quarterback did for the Giants in 2017.
続きを読む »